用户头像
SeekingBiotech新药
 · 上海  

$Biohaven(BHVN)$ 增发PIPE。
BHVN priced a public offering of 23.3M shares at $7.50 each, with expected gross proceeds of ~$175M and a 30-day option for underwriters to purchase up to 3.5M additional shares; proceeds will support general corporate purposes, with closing expected on November 13, 2025
距离峰值,下跌不少。cns